Efficacy of ruxolitinib as inducer of fetal hemoglobin in primary erythroid cultures from sickle cell and beta-thalassemia patients.Published in:Thalassemia Reports, 2019, v. 9, n. 1, p. 1, doi. 10.4081/thal.2019.8101By:Pecoraro, Alice;Troia, Antonio;Maggio, Aurelio;Di Marzo, RosalbaPublication type:Article